464 related articles for article (PubMed ID: 32821097)
41. Cancer cell membrane-coated C-TiO
Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
[TBL] [Abstract][Full Text] [Related]
42. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
43. Biodegradable Nanosonosensitizers with the Multiple Modulation of Tumor Microenvironment for Enhanced Sonodynamic Therapy.
Zhou H; Sun J; Wu J; Wei H; Zhou X
Int J Nanomedicine; 2021; 16():2633-2646. PubMed ID: 33854312
[TBL] [Abstract][Full Text] [Related]
44. Antitumor Effects of a Distinct Sonodynamic Nanosystem through Enhanced Induction of Immunogenic Cell Death and Ferroptosis with Modulation of Tumor Microenvironment.
Yuan H; Ma J; Huang W; Gong P; Shi F; Xu X; Fu C; Wang X; Wong YK; Long Y; Sun X; Li W; Li Z; Wang J
JACS Au; 2023 May; 3(5):1507-1520. PubMed ID: 37234112
[TBL] [Abstract][Full Text] [Related]
45. Photosynthetic Oxygenation-Augmented Sonodynamic Nanotherapy of Hypoxic Tumors.
Lu S; Feng W; Dong C; Song X; Gao X; Guo J; Chen Y; Hu Z
Adv Healthc Mater; 2022 Feb; 11(3):e2102135. PubMed ID: 34787379
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome.
Wang X; Li Y; Wang D; Wang X; Yuan W; Zhao W; Xia G
Pharm Dev Technol; 2021 Jan; 26(1):110-118. PubMed ID: 33104406
[TBL] [Abstract][Full Text] [Related]
47. Bimetallic nanoplatform for synergistic sonodynamic-calcium overload therapy utilizing self-supplied hydrogen peroxide and relieved hypoxia.
Xu W; Zhao Y; Zhang C; Huo M; Wang L; Wu X; Zhang Y; Li Q; Gai Y
Biomater Sci; 2024 Feb; 12(5):1171-1184. PubMed ID: 38205509
[TBL] [Abstract][Full Text] [Related]
48. An Oxygen-Sufficient Nanoplatform for Enhanced Imaging-Guided Microwave Dynamic Therapy Against Hypoxic Tumors.
Yang R; Huang J; Liao M; Huang J; Gao B; Zhang H; Zhou J; Xu J; Lu Q
Int J Nanomedicine; 2022; 17():5525-5545. PubMed ID: 36438610
[TBL] [Abstract][Full Text] [Related]
49. Metal-Phenolic Network-Enabled Lactic Acid Consumption Reverses Immunosuppressive Tumor Microenvironment for Sonodynamic Therapy.
Zhang Z; Li B; Xie L; Sang W; Tian H; Li J; Wang G; Dai Y
ACS Nano; 2021 Oct; 15(10):16934-16945. PubMed ID: 34661387
[TBL] [Abstract][Full Text] [Related]
50. MOF-Derived Double-Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging-Guided Sonodynamic Therapy.
Pan X; Wang W; Huang Z; Liu S; Guo J; Zhang F; Yuan H; Li X; Liu F; Liu H
Angew Chem Int Ed Engl; 2020 Aug; 59(32):13557-13561. PubMed ID: 32374941
[TBL] [Abstract][Full Text] [Related]
51. An ultrasound-controllable ROS-responsive nanoplatform for O
Zhang J; Zhang L; Zhang Y; Ju R; Wei G
Nanoscale; 2023 Dec; 15(48):19638-19649. PubMed ID: 38018873
[TBL] [Abstract][Full Text] [Related]
52. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
53. Erythrocyte Membrane-Camouflaged PCN-224 Nanocarriers Integrated with Platinum Nanoparticles and Glucose Oxidase for Enhanced Tumor Sonodynamic Therapy and Synergistic Starvation Therapy.
Bao Y; Chen J; Qiu H; Zhang C; Huang P; Mao Z; Tong W
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24532-24542. PubMed ID: 34019368
[TBL] [Abstract][Full Text] [Related]
54. Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy.
Han X; Zhou C; Luo X; Pang H; Han C; Tang L; Yang Z; Nong Y; Lu C
Curr Mol Med; 2024; 24(5):648-666. PubMed ID: 37312441
[TBL] [Abstract][Full Text] [Related]
55. Ultrasound-triggered breast tumor sonodynamic therapy through hematoporphyrin monomethyl ether-loaded liposome.
Zhang Y; Ou Y; Guo J; Huang X
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):948-957. PubMed ID: 31389180
[TBL] [Abstract][Full Text] [Related]
56. Tablet-like TiO
Cao J; Sun Y; Zhang C; Wang X; Zeng Y; Zhang T; Huang P
Acta Biomater; 2021 Jul; 129():269-279. PubMed ID: 34082101
[TBL] [Abstract][Full Text] [Related]
57. Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses.
Liu M; Khan AR; Ji J; Lin G; Zhao X; Zhai G
J Control Release; 2018 Nov; 290():150-164. PubMed ID: 30308258
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome.
Xia G; An Z; Wang Y; Zhao C; Li M; Li Z; Ma J
Chem Pharm Bull (Tokyo); 2013; 61(4):390-8. PubMed ID: 23385961
[TBL] [Abstract][Full Text] [Related]
59. Live bio-nano-sonosensitizer targets malignant tumors in synergistic therapy.
Yin C; Li Y; Liao Z; Wang Z; Dai C; Wang W; Yang E; Guo F; Wright IR; Martin LL; Sun D
Acta Biomater; 2023 Jan; 155():491-506. PubMed ID: 36427685
[TBL] [Abstract][Full Text] [Related]
60. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
